Page last updated: 2024-08-23

daunorubicin and Thymus Neoplasms

daunorubicin has been researched along with Thymus Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourgeois, S; Gruol, DJ; Trotter, J; Zee, MC	1
Hama-Inaba, H; Matsushima, T; Mori, M; Muto, M; Ohyama, H; Saitoh, T; Takusagawa, M; Wang, B; Yamada, T	1
Hori, G; Kitami, A; Mitsuya, T; Mori, H; Suzuki, S; Suzuki, T	1
McKenzie, IF; Pietersz, GA; Smyth, MJ	2

Reviews

1 review(s) available for daunorubicin and Thymus Neoplasms

Article	Year
Effective treatment of thymic carcinoma with operation and combination chemotherapy against acute monocyte leukemia: case report and review of the literature. Japanese journal of clinical oncology, 1998, Volume: 28, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Choriocarcinoma; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Monocytic, Acute; Mercaptopurine; Middle Aged; Neoplasms, Multiple Primary; Prednisolone; Thymus Neoplasms; Uterine Neoplasms	1998

Article

Year

Effective treatment of thymic carcinoma with operation and combination chemotherapy against acute monocyte leukemia: case report and review of the literature.

Japanese journal of clinical oncology, 1998, Volume: 28, Issue:9

Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Choriocarcinoma; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Monocytic, Acute; Mercaptopurine; Middle Aged; Neoplasms, Multiple Primary; Prednisolone; Thymus Neoplasms; Uterine Neoplasms

1998

Other Studies

4 other study(ies) available for daunorubicin and Thymus Neoplasms

Article	Year
Reversal of multidrug resistance by RU 486. Cancer research, 1994, Jun-15, Volume: 54, Issue:12 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Colchicine; Daunorubicin; Dexamethasone; Drug Resistance; Female; Kinetics; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mifepristone; Phenotype; Puromycin; Structure-Activity Relationship; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Verapamil	1994
Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation. Mutation research, 1998, Jul-17, Volume: 403, Issue:1-2 Topics: Animals; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Resistance; Genetic Variation; Methyl Methanesulfonate; Mice; Mitomycin; Mutagens; Radiation Tolerance; Sphingosine; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1998
Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates. Journal of the National Cancer Institute, 1987, Volume: 79, Issue:6 Topics: Adrenergic beta-Antagonists; Animals; Antibodies, Monoclonal; Cell Division; Cyclandelate; Daunorubicin; DNA Replication; Idarubicin; Mandelic Acids; Mice; Mice, Inbred Strains; Perfusion; Prazosin; Thymoma; Thymus Neoplasms	1987
Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates. Cancer research, 1988, Feb-15, Volume: 48, Issue:4 Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cell Division; Cell Line; Cell Survival; Daunorubicin; Humans; Idarubicin; Immunotherapy; Mice; Mice, Inbred Strains; Thymoma; Thymus Neoplasms	1988